Insufficient scRNA-seq data for expression of GSPT2 at single-cell level.
Insufficient scRNA-seq data for expression of GSPT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 881.28 | 2633 / 2642 | 100% | 39.31 | 704 / 705 |
thymus | 100% | 506.93 | 651 / 653 | 98% | 17.44 | 594 / 605 |
prostate | 100% | 480.08 | 244 / 245 | 96% | 19.35 | 484 / 502 |
adrenal gland | 100% | 848.73 | 258 / 258 | 96% | 19.93 | 220 / 230 |
pancreas | 97% | 331.44 | 317 / 328 | 92% | 19.74 | 164 / 178 |
kidney | 100% | 431.47 | 89 / 89 | 87% | 10.95 | 786 / 901 |
skin | 93% | 552.20 | 1676 / 1809 | 92% | 17.33 | 434 / 472 |
ovary | 99% | 580.58 | 179 / 180 | 74% | 9.70 | 319 / 430 |
lung | 92% | 433.12 | 534 / 578 | 79% | 12.05 | 907 / 1155 |
breast | 100% | 613.08 | 459 / 459 | 71% | 9.97 | 791 / 1118 |
intestine | 100% | 651.03 | 965 / 966 | 70% | 14.64 | 369 / 527 |
bladder | 100% | 567.67 | 21 / 21 | 67% | 10.38 | 340 / 504 |
stomach | 98% | 435.68 | 353 / 359 | 61% | 12.36 | 174 / 286 |
liver | 100% | 615.03 | 226 / 226 | 57% | 9.14 | 232 / 406 |
esophagus | 94% | 461.22 | 1358 / 1445 | 44% | 5.02 | 80 / 183 |
uterus | 99% | 573.40 | 168 / 170 | 32% | 5.72 | 146 / 459 |
adipose | 100% | 525.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.21 | 29 / 29 |
spleen | 100% | 730.15 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 506.00 | 1318 / 1335 | 0% | 0 | 0 / 0 |
muscle | 96% | 355.57 | 774 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 460.88 | 815 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 12.33 | 75 / 80 |
peripheral blood | 43% | 325.75 | 396 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 40% | 3.52 | 18 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006412 | Biological process | translation |
GO_0000184 | Biological process | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO_0006415 | Biological process | translational termination |
GO_0018444 | Cellular component | translation release factor complex |
GO_0005829 | Cellular component | cytosol |
GO_0005525 | Molecular function | GTP binding |
GO_0003924 | Molecular function | GTPase activity |
GO_0005515 | Molecular function | protein binding |
GO_0003747 | Molecular function | translation release factor activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | GSPT2 |
Protein name | Eukaryotic peptide chain release factor GTP-binding subunit ERF3B (Eukaryotic peptide chain release factor subunit 3b) (eRF3b) (EC 3.6.5.-) (G1 to S phase transition protein 2 homolog) |
Synonyms | ERF3B |
Description | FUNCTION: GTPase component of the eRF1-eRF3-GTP ternary complex, a ternary complex that mediates translation termination in response to the termination codons UAA, UAG and UGA . GSPT2/ERF3B mediates ETF1/ERF1 delivery to stop codons: The eRF1-eRF3-GTP complex binds to a stop codon in the ribosomal A-site . GTP hydrolysis by GSPT2/ERF3B induces a conformational change that leads to its dissociation, permitting ETF1/ERF1 to accommodate fully in the A-site . Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons . . |
Accessions | ENST00000340438.6 Q8IYD1 |